Show Notes
Are statin side effects like muscle aches and brain fog as common as you've heard? In this deep dive, I break down the real data on statin intolerance, explain the powerful "nocebo effect" (where negative expectations cause real symptoms), and walk you through the exact management strategies we use in clinic. We'll also cover all the non-statin alternatives available today, giving you a complete, evidence-based framework for this important conversation.
Stop stressing over every health detail & start living! My FREE 'Necessary Nine' PDF cuts through the noise, giving you the essential things you need for a healthy life.
➡️ Download Here: https://www.jrennickemd.com/necessaryninepdf
CHAPTERS: 00:00 - Intro 01:14 - The Statin Paradox 02:42 - Statin Intolerance Definition 03:45 - The “Two Statin” Rule 05:03 - Complete vs Partial Intolerance 06:58 - Prevalence 08:26 - The Spectrum of Statin Side Effects 08:58 - Statin Associated Muscle Symptoms (SAMS) 11:12 - Why SAMS Occur 14:29 - Statin and Diabetes 17:30 - Statins and Brain Fog/Dementia 19:37 - Statins and the Liver 20:34 - The Nocebo Effect 21:56 - GAUSS-3 Trial 22:55 - SAMSON Trial 24:15 - The Power of Educating Patients 25:23 - Initial Patient Evaluation 27:49 - The “De-Challenge” Period 29:23 - Re-Challenging Patients 31:03 - Patient Education 32:24 - Non Statin Medications: Ezetimibe 33:38 - Non Statin Medications: PCSK9 inhibitors 34:32 - Non Statin Medications: Bempedoic Acid 35:35 - Non Statin Medications: Inclisiran 36:25 - Non Statin Medications: Comparison 37:19 - Key Takeaways
SELECTED REFERENCES:
Clinician use of the Statin Choice Shared Decision-making Encounter Tool in a Major Health System - PMC, accessed August 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11255133/
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients ..., accessed August 10, 2025, https://pubmed.ncbi.nlm.nih.gov/27039291/
2018 Guideline on the Management of Blood Cholesterol - American College of Cardiology, accessed August 10, 2025, https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2018/Guidelines-Made-Simple-Tool-2018-Cholesterol.pdf
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs - JACC Journals, accessed August 10, 2025, https://www.jacc.org/doi/10.1016/j.jacc.2024.04.048
NLA Scientific Statement on Statin Intolerance: A New Definition and ..., accessed August 10, 2025, https://www.lipid.org/sites/default/files/files/Statin%20Intolerance%20A%20New%20Definition%20%26%20Key%20Considerations%20(JPP).pdf
Statin Intolerance | Circulation - American Heart Association Journals, accessed August 10, 2025, https://www.ahajournals.org/doi/10.1161/circulationaha.114.013189
Prevalence of statin intolerance: a meta-analysis | European Heart Journal | Oxford Academic, accessed August 10, 2025, https://academic.oup.com/eurheartj/article/43/34/3213/6529098
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction - JACC Journals, accessed August 10, 2025, https://www.jacc.org/doi/10.1016/j.jacc.2016.12.036
Diagnosis and Management of Statin Intolerance - PMC, accessed August 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6402887/
a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient - PubMed, accessed August 10, 2025, https://pubmed.ncbi.nlm.nih.gov/35718660/
https://link.springer.com/article/10.1007/s11886-022-01729-x
*Disclaimer*
This podcast is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.